Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
PHASE1CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
July 31, 1998
Study Completion Date
May 31, 2003
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG
amifostine trihydrate
DRUG
paclitaxel
Trial Locations (1)
13210
State University of New York - Upstate Medical University, Syracuse
All Listed Sponsors
lead
State University of New York - Upstate Medical University
OTHER
NCT00003555 - Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | Biotech Hunter | Biotech Hunter